Lopende projecten

In dit overzicht vindt u informatie over lopende onderzoeken waarbij data van SHM worden gebruikt. De lijst is gefilterd en toont alleen projecten die beschikbaar zijn voor een breed publiek. Wilt u meer weten over de stand van zaken in een project of een overzicht van de laatste publicaties, bekijk dan de publicaties in ons jaarverslag.

 Bekijk het laatste jaarverslag

SHM nr. Titel project Auteur(s)
I04034 The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) P. Reiss
I05513 HIV Resistance Response Database Initiative (RDI) A. Revell
I08115 Proposal for collaboration and data exchange between HMF and RIVM for nation HIV/AIDS surveillance and data transfer to ECDC in the context of EU obligations for reporting on HIV/AIDS E. op den Coul, F. de Wolf, M. van der Sande, 
A. van Sighem, 
J. Vlug
I10021 Characteristics of HIV-1 transmission among men having sex with men in the Netherlands O. Ratmann
I12045 A HIV-1 genome wide association study to identify viral determinants of HIV-1 plasma concentration (BEEHIVE) F. de Wolf, B. Berkhout, M. Cornelissen, C. Fraser, P. Kellam, A. Gall, L. Gras, A. van Sighem
I13032 Combined and Comparative Analysis of Virulence Trends Across Multiple Cohorts L. Gras, F. de Wolf, J. Herbeck, V. Mueller
I13051 Barrières voor hiv-preventie, -testen en -zorg onder migranten (aMASE) M. Prins, F. Zuure, J. Bil, F. Burns, J. del Amo
I13120 SPREAD Program 3.0 - Surveillance of transmission of HIV- drug resistace A.M.J. Wensing, C.A.B. Boucher, K. Brinkman, J. van der Meer, I. van de Ende, C. Richter, E. Schippers, D. de Vries-Sluijs, J. Schinkel, C. Smit
I14065 Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients: Implications for screening strategies G. Wandeler, A. Rauch, P. Reiss, C. Smit, M. van der Valk, J. Arends
I14067 Predictive value of cardiovascular risk equations in the HIV-infected population receiving care in the Dutch HIV treatment centers F. Wit, R. van Zoest, I. Vaartjes. L. Gras, J. Arends, P. Reiss
I14087 Clinical experience with rilpivirine (KLII study) E. Roelofsen, D.M. Burger, D.J. Touw, L.B.S. Gelinck, E.B. Wilms
I14096  Primary and recurrent venous thromboembolism in Hiv-1 (PREDICT study) J. Borjas-Howard, B.J.A. Rijnders, C. Rokx, Y.I.G.V. Tichelaar, A. Verbon, K. Meijer
I14144 Geographical Information System to determine high prevalence aeras of targeted screening and early case-finding I. Joore, J. van Bergen, E. op de Coul, A. van Sighem, J. Prins, S. Geerlings
I14145 Evaluation of an evidence-based, Internet-supported self-help program for people living with HIV suffering from mild to moderate depressive symptoms N. Garnefski, V. Kraaij, S. van Luenen
I14157 Overlap between HIV and HCV networks among MSM with HIV/HCV coinfection J. Vanhommerig, J. Schinkel, D. Bezemer, T. van de laar, A. van Sighem, C. Smit, M. Prins
I15004 The impact of combinations of strategies for HIV prevention among men who have sex with men M. Xiridu, A. van den Bosch, B. van Benthem, E. Op de Coul, A. van Sighem, I. Stolte
I15021

Global resistance following virologic failure with tenofovir +NNRTI containing antiretroviral regimens: a retrospective multi-centre multi-cohort study and meta-analysis 

 

C. Rokx, R. Gupta, B. Rijnders, B. Shafer, J. Gregson, M. Tang, R. Hamers, E. Raizes, K. Crawford, V. Marconi, A. Hill, M. Hosseinipour, N. Clumeck, P. Kanki, S. Lockman, T. Rinke de Wit,
S. Hoffman, T. de Oliveira, C. Wallis, L. Morris, G. Hunt, D. Dunn, J.L. Blanco, H. Gunthard, Dr. Kumarasamy, P. Kaleebu, D. Pillay, C. Charpentier, D. Descamps, A. van Damme, K. Theys, R. Camacho, V. Calvez, L. Gras.
I15022 Community viral load as a tool for HIV surveillance in the Netherlands and South Africa E. Op de Coul, R. Bolijn, J. Heijne, A. van Sighem, 
M. Kretzschmar, HIV Behandelaar
I15040 Monitoring recent HIV infection in the Netherlands: implementation of Recent Infection Testing Algorithm (RITA) into routine HIV surveillance E. Op de Coul, G. de Bree, A. van Sighem, K. Brinkman, J. Prins, S. Jurriaans. 
I15043 Cost-effectiveness of the Adherence Improving self-Management Strategy (AIMS) in HIV-care: A model-based economic evaluation M. de Bruin, J. Prins, E. Oberjé, M. Hiligsmann, S. Evers, L. Gras 
I15065 Comparison of the occurrence of severe HBV-related liver disease and (liver-related) mortality between patients with hepatitis B mono-infection and patients coinfected with hepatitis B and HIV in the Netherlands. (HARMONIC) J.E. Arends, C. Richter, F.I. Lieveld, P. Reiss, C. Smit, M. Spanier, K.J. van Erpecum, I.M. Hoepelman
I15066

Cost-effectiveness of HIV treatment and care in the Netherlands

A. Verbon, B.E. Nichols, C. Boucher, S. Geerlings, P. Reiss, A. van Sighem, F.P. Kroon, M.J. Postma, K. Brinkman
I15090

Fibrosis progression after acute HCV infection in HIV-infected individuals

M. van de Valk, K.W. Kooij, A. Newsum, C. Smit, P. reiss, M. Prins, J. van der Meer, MOSAIC Study Group, SHM Werkgroep Hepatitis
I15142

Use of regular outpatient medication n HIV/HCV co-infected patients in the Netherlands

E.J. Smolders, C. Smit, C.T.M.M. De Kanter, A.S.M. Dofferhoff, J.E. Arends, K. Brinkman, B. Rijnders, M. van der Valk, P. Reiss, D.M. Burger, on behalf of the ATHENA national HIV obsercational cohort.  
I16011

Type of cART regimen and the risk for immune reconstitution and inflammatory syndrome in HIV-1 infected patients. Is integrase inhibitor use an independent risk factor? 

I.E.A. Wijting, C. Rokx, F.W.N.M. Wit, P. Reiss, B.J.A. Rijnders
I16038

Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients: a multicentre cohort study

P.H. Ward, W. van Bisen, C.H.S.B. van den Berg, B.J.A. Rijnders, K. Brinkman, J.W. Mulder, L.B.S. Gelinck, A.I.M. Hoepelman, F.W.N.M. Wit, D. van de Beek, J.M. Prins
I16060

Evaluation of dolutegravir use of the treatment of HIV in the Netherlands: focus on switchers and adverse events

D. Burger, R. van Crevel, A. Brouwer, P. Bollen, J.E. Arends, C.S. Hakkers, I.M. Hoepelman, K. Brinkman, G.E.L. van den Berk, F. IWit
I16072

Comparison of the occurence of HBV-related liver disease and (liver-related) mortality between patients with hepatitis B mono-infection and patients co-infected with hepatitis B and HIV in the Netherlands (HARMONIC 2)

J.E. Arends, C.M. Richter, F.I. Lieveld, P. Reiss, C. Smit, M. Spaier, K.J. Erpecum, I.M. Hoepelman
I17092

Impact of the Positive Sisters peer support program on health outcomes in HIV-positive migrant women in the Netherlands

F. Cobelens, L. Darvey, M. Adhikari, S. Boender